Latisse is the first and only FDA-approved treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes. Latisse eyelash growth treatment is a prescription treatment for hypotrichosis, or inadequate eye lash growth. The quick and simple daily-once application of Latisse to the base of the upper eyelashes results in the growth of more beautiful long lashes. By extending the growth phase of the eye lash lifecycle, the treatment allows for more eyelash growth for a longer period of time, creating longer, thicker and more beautiful eyelashes.
Latisse eyelash growth users may experience thicker, more youthful eyelashes in as little as 6 weeks, with full results in 16 weeks. To maintain long term results, Latisse solution should be used continuously with the prescription of the doctor. The most common side effects after using Latisse are eye itching or eye redness, which gets resolved in few days.
Latisse is a FDA approved prescription treatment used to make the eyelashes longer, thicker and darker. Latisse is also used to treat certain diseases of the eye like open-angle glaucoma and ocular hypertension which occurs in many people as they grow older. It is safe to use Latisse while breastfeeding.
The active ingredient in Latisse is bimatoprost ophthalmic. It may be used to treat open angle glaucoma and ocular hypertension. The drug is unlikely to enter the milk compartment due to its low plasma levels and high protein binding. Latisse is applied directly on the lashes and therefore unlikely to be absorbed systemically. Latisse is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase; and second, it increases the number of hairs in this growth phase.
Hence, there is no confirmed research that Latisse while breastfeeding is harmful. But it is better to consult a cosmetic surgeon before using it.